Total Payments
$92,900
2024 Payments
$29,215
Companies
28
Transactions
626
Medicare Patients
1,932
Medicare Billing
$267,768
Payment Breakdown by Category
Other$50,833 (54.7%)
Consulting$18,350 (19.8%)
Food & Beverage$12,657 (13.6%)
Travel$10,479 (11.3%)
Education$581.40 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,038 | 20 | 50.6% |
| Consulting Fee | $18,350 | 9 | 19.8% |
| Food and Beverage | $12,657 | 567 | 13.6% |
| Travel and Lodging | $10,479 | 21 | 11.3% |
| Honoraria | $3,795 | 1 | 4.1% |
| Education | $581.40 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $44,860 | 108 | $0 (2024) |
| ABBVIE INC. | $14,563 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,878 | 9 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $6,153 | 12 | $0 (2024) |
| Horizon Therapeutics plc | $5,462 | 22 | $0 (2023) |
| PFIZER INC. | $4,478 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $2,150 | 5 | $0 (2024) |
| Amgen Inc. | $1,352 | 69 | $0 (2024) |
| UCB, Inc. | $1,337 | 69 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,067 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,215 | 191 | Janssen Biotech, Inc. ($22,343) |
| 2023 | $47,694 | 275 | Janssen Biotech, Inc. ($12,467) |
| 2022 | $15,629 | 156 | Janssen Biotech, Inc. ($10,051) |
| 2019 | $100.00 | 1 | Genentech USA, Inc. ($100.00) |
| 2018 | $191.00 | 2 | Genentech USA, Inc. ($100.00) |
| 2017 | $70.92 | 1 | AbbVie, Inc. ($70.92) |
All Payment Transactions
626 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Immunology | ||||||
| 12/18/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $21.59 | General |
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Immunology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $114.52 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Travel and Lodging | Cash or cash equivalent | $83.75 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.74 | General |
| 10/26/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 739 | 4,094 | $354,684 | $123,035 |
| 2022 | 10 | 490 | 924 | $179,749 | $65,431 |
| 2021 | 9 | 349 | 518 | $123,500 | $43,215 |
| 2020 | 9 | 354 | 482 | $113,685 | $36,088 |
Total Patients
1,932
Total Services
6,018
Medicare Billing
$267,768
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,860 | $89,400 | $34,187 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 379 | $101,572 | $34,066 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 72 | 72 | $33,264 | $10,757 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $29,050 | $9,935 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 58 | $21,924 | $8,177 | 37.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 61 | $17,873 | $6,575 | 36.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 31 | 123 | $17,835 | $6,379 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 102 | $19,482 | $5,763 | 29.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 46 | 79 | $11,040 | $4,266 | 38.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 157 | $4,867 | $1,808 | 37.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 59 | 592 | $5,920 | $491.55 | 8.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 11 | 55 | $1,152 | $310.81 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 34 | $1,190 | $277.38 | 23.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 439 | $114.14 | $42.87 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 267 | $71,704 | $25,862 | 36.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 80 | 80 | $36,960 | $13,851 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $21,044 | $8,096 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 47 | $17,766 | $6,887 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 81 | $15,495 | $5,269 | 34.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 20 | 45 | $6,525 | $2,422 | 37.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 24 | 42 | $5,962 | $2,304 | 38.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 39 | $1,209 | $461.40 | 38.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 31 | 245 | $2,454 | $224.53 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 18 | $630.00 | $52.92 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 198 | $53,910 | $19,510 | 36.2% |
About Deepan Dalal, MD, MPH
Deepan Dalal, MD, MPH is a Rheumatology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1962720441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deepan Dalal, MD, MPH has received a total of $92,900 in payments from pharmaceutical and medical device companies, with $29,215 received in 2024. These payments were reported across 626 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,038).
As a Medicare-enrolled provider, Dalal has provided services to 1,932 Medicare beneficiaries, totaling 6,018 services with total Medicare billing of $267,768. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Cranston, RI
- Active Since 05/10/2010
- Last Updated 01/20/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1962720441
Products in Payments
- TREMFYA (Drug) $33,746
- SIMPONI ARIA (Biological) $17,081
- OFEV (Drug) $8,866
- KRYSTEXXA (Biological) $5,514
- XELJANZ (Drug) $4,454
- RINVOQ (Biological) $1,194
- Cimzia (Drug) $1,012
- SAPHNELO (Biological) $976.32
- Enbrel (Biological) $855.87
- SKYRIZI (Biological) $585.85
- ACTHAR (Biological) $552.62
- BENLYSTA (Biological) $411.50
- Rituxan (Biological) $338.78
- TALTZ (Drug) $242.90
- EVENITY (Biological) $213.65
- Bimzelx (Biological) $197.30
- REMICADE (Biological) $186.37
- KINERET (Drug) $173.91
- TAVNEOS (Drug) $148.32
- Kineret (Drug) $122.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.